HIV and ID Observations

November 15th, 2020

Bamlanivimab for COVID-19 — Hard to Pronounce, Even Harder to Give

The latest COVID-19 treatment made available under Emergency Use Authorization (EUA) is bamlanivimab, a monoclonal antibody developed by Eli Lilly. For now, its use will be limited to outpatients who are at high risk for severe disease and/or hospitalization. This EUA is based on the results of the phase 2 BLAZE-1 study, in which the treatment […]

---